Cargando…
Immunogenicity and Tumorigenicity of Pluripotent Stem Cells and their Derivatives: Genetic and Epigenetic Perspectives
One aim of stem cell-based therapy is to utilize pluripotent stem cells (PSCs) as a supplementary source of cells to repair or replace tissues or organs that have ceased to function due to severe tissue damage. However, PSC-based therapy requires extensive research to ascertain if PSC derivatives ar...
Autores principales: | Tan, Yuan, Ooi, Sarah, Wang, Lisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873036/ https://www.ncbi.nlm.nih.gov/pubmed/24160683 http://dx.doi.org/10.2174/1574888X113086660068 |
Ejemplares similares
-
“Mouse Clone Model” for evaluating the immunogenicity and tumorigenicity of pluripotent stem cells
por: Zhang, Gang, et al.
Publicado: (2015) -
Tumorigenic and Immunogenic Properties of Induced Pluripotent Stem Cells: a Promising Cancer Vaccine
por: Qiao, Yu, et al.
Publicado: (2020) -
Epigenetic mechanisms of tumorigenicity manifesting in stem cells
por: Tung, Po-Yuan, et al.
Publicado: (2014) -
The Tumorigenic Potential of Human Pluripotent Stem Cells
por: Lezmi, Elyad, et al.
Publicado: (2022) -
The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives
por: Liu, Xin, et al.
Publicado: (2017)